Financials
- Market Capitalization 3.75 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
0.03
売上高対価格比率
0.01
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1535 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.35 USD | -2.15% | -9.33% | -16.70% | +237.61% | 3.77 B USD | ||
| 1536 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 33.81 USD | +0.18% | -8.94% | +66.63% | +239.80% | 3.77 B USD | ||
| 1543 | DNLI Denali Therapeutics Inc. - Common Stock | 23.27 USD | -2.06% | -5.98% | +1.84% | +43.91% | 3.72 B USD | ||
| 1555 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.85 USD | -2.16% | -4.32% | +6.37% | +71.95% | 3.68 B USD |